BAY 2416964
规格
| Cas Number | 2242464-44-2 |
| 规格或纯度 | 10mM in DMSO |
| 包装 | 1ml |
产品信息
| 品牌 | 阿拉丁 |
| 浓度 | 10mM in DMSO |
| 简短描述 | AhR拮抗剂 |
| 英文简短描述 | AhR Antagonists |
| 过滤标签 | Compound libraries |
| 储存温度 | -80℃储存 |
| 运输条件 | 超低温冰袋运输 |
| 生化和生理学机理 | BAY 2416964（化合物 192）是一种有效的芳基烃受体（AhR）口服活性拮抗剂，IC50 为 341 nM。BAY 2416964 具有治疗实体瘤的潜力。 |
| 描述 |
BAY 2416964 是一种有效的,口服活性的芳基烃受体 (AHR) 拮抗剂，其 IC50 为 341 nM，可用于实体瘤的研究。详细信息请参考专利文献 WO2018146010A1 中的化合物 192。 |
| 英文描述 |
Information BAY 2416964 BAY 2416964 (compound 192) is a potent and orally active antagonist of aryl hydrocarbon receptor (AhR) with IC50 of 341 nM. BAY 2416964 has the potential in the treatment of solid tumors. Targets AhR (Cell-free assay) 341 nM In vitro BAY 2416964 (Example 192) induces AHR-regulated gene CYP1A1 expression with IC50 of 4.30 nM in a human monocytic U937 cells. In vivo In vivo assays: BAY 2416964 (Example 192) is dissolved in Ethanol/Solutol/Water (10/40/50) and given at 30 mg/kg, QD, p.o.. The efficacy is calculated based on tumor volume. BAY 2416964 (Example 192) is shown to have the potential for solid tumour treatment. Cell Research(from reference) Cell lines：human monocytic U937 cell line Concentrations：3.1 nmol/L, 11 nmol/L, 38 nmol/L, 130 nmol/L, 470 nmol/L, 1.6 pmol/L, 5.7 pmol/L and 20 pmol/L Incubation Time：20 h |